X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs PFIZER - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS PFIZER J.B.CHEMICALS/
PFIZER
 
P/E (TTM) x 14.7 31.0 47.4% View Chart
P/BV x 2.3 4.9 47.2% View Chart
Dividend Yield % 0.2 0.7 25.4%  

Financials

 J.B.CHEMICALS   PFIZER
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
PFIZER
Mar-16
J.B.CHEMICALS/
PFIZER
5-Yr Chart
Click to enlarge
High Rs3182,724 11.7%   
Low Rs2001,611 12.4%   
Sales per share (Unadj.) Rs148.0440.9 33.6%  
Earnings per share (Unadj.) Rs19.148.7 39.2%  
Cash flow per share (Unadj.) Rs23.975.8 31.6%  
Dividends per share (Unadj.) Rs0.5015.00 3.3%  
Dividend yield (eoy) %0.20.7 27.9%  
Book value per share (Unadj.) Rs128.9462.9 27.9%  
Shares outstanding (eoy) m84.8245.75 185.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.74.9 35.6%   
Avg P/E ratio x13.644.5 30.5%  
P/CF ratio (eoy) x10.828.6 37.8%  
Price / Book Value ratio x2.04.7 42.9%  
Dividend payout %2.630.8 8.5%   
Avg Mkt Cap Rs m21,95199,163 22.1%   
No. of employees `0002.72.9 94.6%   
Total wages/salary Rs m1,8412,758 66.8%   
Avg. sales/employee Rs Th4,590.96,981.7 65.8%   
Avg. wages/employee Rs Th673.4954.5 70.6%   
Avg. net profit/employee Rs Th592.1771.1 76.8%   
INCOME DATA
Net Sales Rs m12,55120,170 62.2%  
Other income Rs m542857 63.2%   
Total revenues Rs m13,09321,028 62.3%   
Gross profit Rs m2,0554,310 47.7%  
Depreciation Rs m4121,239 33.3%   
Interest Rs m965 1,840.4%   
Profit before tax Rs m2,0883,923 53.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m4691,794 26.1%   
Profit after tax Rs m1,6192,228 72.7%  
Gross profit margin %16.421.4 76.6%  
Effective tax rate %22.545.7 49.1%   
Net profit margin %12.911.0 116.8%  
BALANCE SHEET DATA
Current assets Rs m7,77816,299 47.7%   
Current liabilities Rs m4,3587,594 57.4%   
Net working cap to sales %27.243.2 63.1%  
Current ratio x1.82.1 83.2%  
Inventory Days Days5565 83.8%  
Debtors Days Days8026 310.8%  
Net fixed assets Rs m5,7138,622 66.3%   
Share capital Rs m170458 37.1%   
"Free" reserves Rs m10,54720,722 50.9%   
Net worth Rs m10,93721,180 51.6%   
Long term debt Rs m025 0.0%   
Total assets Rs m15,57429,137 53.5%  
Interest coverage x22.8755.5 3.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.7 116.4%   
Return on assets %11.07.7 143.6%  
Return on equity %14.810.5 140.7%  
Return on capital %20.019.0 105.1%  
Exports to sales %48.70.1 81,889.0%   
Imports to sales %7.117.5 40.5%   
Exports (fob) Rs m6,11512 50,957.5%   
Imports (cif) Rs m8893,526 25.2%   
Fx inflow Rs m6,16952 11,943.9%   
Fx outflow Rs m1,285140 918.1%   
Net fx Rs m4,884-88 -5,529.1%   
CASH FLOW
From Operations Rs m1,3973,436 40.6%  
From Investments Rs m-320-6,991 4.6%  
From Financial Activity Rs m-1,196-619 193.2%  
Net Cashflow Rs m-102-4,174 2.5%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 63.9 0.5%  
Indian inst/Mut Fund % 3.4 7.5 45.2%  
FIIs % 3.9 4.9 79.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 23.7 156.1%  
Shareholders   30,437 85,207 35.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  CADILA HEALTHCARE  GSK PHARMA  PANACEA BIOTECH  

Compare J.B.CHEMICALS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 19, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS